Hot Pursuit     05-Mar-25
Biocon Ltd up for third straight session
Biocon Ltd is quoting at Rs 320.8, up 1.91% on the day as on 12:49 IST on the NSE. The stock is up 16.87% in last one year as compared to a 0.46% slide in NIFTY and a 4.57% slide in the Nifty Pharma index.

Biocon Ltd is up for a third straight session today. The stock is quoting at Rs 320.8, up 1.91% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 1.3% on the day, quoting at 22369.85. The Sensex is at 73855.47, up 1.19%. Biocon Ltd has slipped around 19.18% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has slipped around 9.06% in last one month and is currently quoting at 19820.65, up 0.98% on the day. The volume in the stock stood at 24.03 lakh shares today, compared to the daily average of 35.14 lakh shares in last one month.

The benchmark March futures contract for the stock is quoting at Rs 321.75, up 1.98% on the day. Biocon Ltd is up 16.87% in last one year as compared to a 0.46% slide in NIFTY and a 4.57% slide in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending December 24.

Previous News
  Biocon Ltd rises for third consecutive session
 ( Hot Pursuit - 17-Apr-26   13:05 )
  Biocon gains after receiving US FDA approval for type-2 diabetes treatment drug Dapagliflozin
 ( Hot Pursuit - 08-Apr-26   11:05 )
  Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg
 ( Corporate News - 08-Apr-26   09:18 )
  Biocon launches biosimilars - Bosaya™ and Aukelso™ in U.S.
 ( Corporate News - 07-Apr-26   19:52 )
  Biocon announces major leadership reshuffle
 ( Hot Pursuit - 27-Mar-26   13:00 )
  Biocon approves change in CFO
 ( Corporate News - 27-Mar-26   12:12 )
  Biocon appoints Shreehas Tambe as CEO and MD
 ( Corporate News - 27-Mar-26   12:03 )
  Biocon board accepts resignation of Siddharth Mittal as CEO and MD
 ( Corporate News - 27-Mar-26   11:58 )
  Biocon gets USFDA nod for Liraglutide injection gVictoza
 ( Hot Pursuit - 13-Mar-26   09:24 )
  Biocon Ltd soars 0.99%, gains for fifth straight session
 ( Hot Pursuit - 25-Feb-26   13:00 )
  Biocon receives USFDA approval for Liraglutide
 ( Corporate News - 25-Feb-26   12:05 )
Other Stories
  SML Mahindra Q4 PAT rises 2% YoY to Rs 54 cr
  20-Apr-26   18:42
  Vedanta clears demerger plan, sets 1 May 2026 as record date
  20-Apr-26   17:50
  Interarch Building Solutions bags Rs 80-cr order for pre-engineered steel buildings
  20-Apr-26   17:10
  ICICI Bank ends higher after net profit rises over 8% to Rs 13,702 crore in Q4
  20-Apr-26   16:59
  Bank of Maharashtra posts strong Q4 FY26 earnings; PAT jumps 35% YoY
  20-Apr-26   16:55
  PNB Gilts clocks PAT of Rs 12.99 crore in Q4
  20-Apr-26   16:23
  Navkar Corporation reports turnaround Q4 numbers
  20-Apr-26   15:48
  Deccan Gold soars as Jonnagiri mine nears launch
  20-Apr-26   15:22
  Indian Energy Exchange Ltd leads losers in 'A' group
  20-Apr-26   15:00
  PNGS Reva Diamond Jewellery gains on strong Akshay Tritiya sales
  20-Apr-26   14:50
Back Top